Literature DB >> 22370643

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.

Y-N Liu1, J J Yin, W Abou-Kheir, P G Hynes, O M Casey, L Fang, M Yi, R M Stephens, V Seng, H Sheppard-Tillman, P Martin, K Kelly.   

Abstract

Epithelial-mesenchymal transition (EMT) is a developmental program of signaling pathways that determine commitment to epithelial and mesenchymal phenotypes. In the prostate, EMT processes have been implicated in benign prostatic hyperplasia and prostate cancer progression. In a model of Pten- and TP53-null prostate adenocarcinoma that progresses via transforming growth factor β-induced EMT, mesenchymal transformation is characterized by plasticity, leading to various mesenchymal lineages and the production of bone. Here we show that SLUG is a major regulator of mesenchymal differentiation. As microRNAs (miRs) are pleiotropic regulators of differentiation and tumorigenesis, we evaluated miR expression associated with tumorigenesis and EMT. Mir-1 and miR-200 were reduced with progression of prostate adenocarcinoma, and we identify Slug as one of the phylogenetically conserved targets of these miRs. We demonstrate that SLUG is a direct repressor of miR-1 and miR-200 transcription. Thus, SLUG and miR-1/miR-200 act in a self-reinforcing regulatory loop, leading to amplification of EMT. Depletion of Slug inhibited EMT during tumorigenesis, whereas forced expression of miR-1 or miR-200 inhibited both EMT and tumorigenesis in human and mouse model systems. Various miR targets were analyzed, and our findings suggest that miR-1 has roles in regulating EMT and mesenchymal differentiation through Slug and functions in tumor-suppressive programs by regulating additional targets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370643      PMCID: PMC7580497          DOI: 10.1038/onc.2012.58

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.

Authors:  Yen-Nien Liu; Wassim Abou-Kheir; Juan Juan Yin; Lei Fang; Paul Hynes; Orla Casey; Dong Hu; Yong Wan; Victoria Seng; Heather Sheppard-Tillman; Philip Martin; Kathleen Kelly
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

2.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

Authors:  Esmeralda Casas; Jihoon Kim; Andrés Bendesky; Lucila Ohno-Machado; Cecily J Wolfe; Jing Yang
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

3.  Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Authors:  Chi-Ping Day; John Carter; Carrie Bonomi; Dominic Esposito; Bruce Crise; Betty Ortiz-Conde; Melinda Hollingshead; Glenn Merlino
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-19       Impact factor: 4.693

4.  Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.

Authors:  P Wikström; P Stattin; I Franck-Lissbrant; J E Damber; A Bergh
Journal:  Prostate       Date:  1998-09-15       Impact factor: 4.104

5.  Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.

Authors:  JuanJuan Yin; Claire Pollock; Kirsten Tracy; Monika Chock; Philip Martin; Michael Oberst; Kathleen Kelly
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

6.  A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.

Authors:  Paloma Alonso-Magdalena; Clemens Brössner; Angelika Reiner; Guojun Cheng; Nobuhiro Sugiyama; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

7.  p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

Authors:  Chun-Ju Chang; Chi-Hong Chao; Weiya Xia; Jer-Yen Yang; Yan Xiong; Chia-Wei Li; Wen-Hsuan Yu; Sumaiyah K Rehman; Jennifer L Hsu; Heng-Huan Lee; Mo Liu; Chun-Te Chen; Dihua Yu; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

8.  p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

Authors:  Alina Molchadsky; Igor Shats; Naomi Goldfinger; Meirav Pevsner-Fischer; Melissa Olson; Ariel Rinon; Eldad Tzahor; Guillermina Lozano; Dov Zipori; Rachel Sarig; Varda Rotter
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

9.  The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK.

Authors:  Neil J Ganem; Duane A Compton
Journal:  J Cell Biol       Date:  2004-08-09       Impact factor: 10.539

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  143 in total

1.  A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster.

Authors:  Xiao Ling Li; Toshifumi Hara; Youngeun Choi; Murugan Subramanian; Princy Francis; Sven Bilke; Robert L Walker; Marbin Pineda; Yuelin Zhu; Yuan Yang; Ji Luo; Lalage M Wakefield; Thomas Brabletz; Ben Ho Park; Sudha Sharma; Dipanjan Chowdhury; Paul S Meltzer; Ashish Lal
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

2.  Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.

Authors:  Y M Yang; W H Lee; C G Lee; J An; E-S Kim; S H Kim; S-K Lee; C H Lee; D N Dhanasekaran; A Moon; S Hwang; S J Lee; J-W Park; K M Kim; S G Kim
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

Review 3.  The roles of microRNAs in the progression of castration-resistant prostate cancer.

Authors:  Satoko Kojima; Yusuke Goto; Yukio Naya
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

4.  MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Authors:  Eiji Osaka; Xiaoqian Yang; Jacson K Shen; Pei Yang; Yong Feng; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2014-04-24       Impact factor: 3.494

Review 5.  Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs.

Authors:  Samy Lamouille; Deepa Subramanyam; Robert Blelloch; Rik Derynck
Journal:  Curr Opin Cell Biol       Date:  2013-02-20       Impact factor: 8.382

6.  Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells.

Authors:  Koichiro Tsukasa; Qiang Ding; Makoto Yoshimitsu; Yumi Miyazaki; Shyuichiro Matsubara; Sonshin Takao
Journal:  Hum Cell       Date:  2015-05-22       Impact factor: 4.174

Review 7.  MicroRNAs in prostate cancer: From function to biomarker discovery.

Authors:  Ahmed A Moustafa; Hogyoung Kim; Rasha S Albeltagy; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2018-06

Review 8.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

9.  Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.

Authors:  Juliane Colditz; Benjamin Rupf; Caroline Maiwald; Aria Baniahmad
Journal:  Mol Cell Biochem       Date:  2016-08-25       Impact factor: 3.396

10.  microRNAs and Prostate Cancer.

Authors:  Sajni Josson; Leland W K Chung; Murali Gururajan
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.